Drug Shortage Report for HAVRIX 1440

Last updated on 2019-08-03 History
Report ID 76695
Drug Identification Number 02187078
Brand name HAVRIX - SUS IM 1440 ELISA UNITS/ML
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 1440UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-14
Estimated end date 2019-10-01
Actual end date 2019-08-02
Shortage status Resolved
Updated date 2019-08-03
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-02-22 English Compare
v2 2019-02-22 French Compare
v3 2019-03-01 English Compare
v4 2019-03-01 French Compare
v5 2019-07-05 English Compare
v6 2019-07-05 French Compare
v7 2019-07-24 English Compare
v8 2019-07-24 French Compare
v9 2019-08-02 English Compare
v10 2019-08-02 French Compare
v11 2019-08-03 English Compare

Showing 1 to 11 of 11